Event
Third FDA/Alzheimer’s Disease Allies Meeting
ACT-AD, together with the Alzheimer’s Foundation of America, and the Alzheimers Drug Discovery Foundation, hosted an FDA/Alzheimer’s Disease Allies Meeting to bring together researchers, clinicians, regulators, drug developers and advocacy groups to discuss challenges in recent Alzheimer’s disease drug development and explore novel approaches to improving the way in which Phase II trials for disease-modifying therapies are designed in the future.
View Agenda
View Transcript
More Upcoming Events
-
Jan03
13th Annual FDA/ACT-AD Allies Meeting – Common Threads: Learning from the Related Dementias
The Accelerate Cures/Treatments for All Dementias (ACT-AD) Coalition’s 13th virtual annual meeting will explore the…